Summit Therapeutics Inc. (SMMT) stock
SMMTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$10.67−1.15 (-9.73%)
Close on Nov 17, 2026Market cap $8.51BP/E –Yield –
Summit Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Summit Therapeutics's total debt was $0 at Dec 31, 2024. For fiscal 2024 it was $0, down 100.0% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $0 | -100.0% |
| FY2023 | Dec 31, 2023 | $100.00M | -79.8% |
| FY2022 | Dec 31, 2022 | $494.54M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $0 | -100.0% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $0 | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $0 | -100.0% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $100.00M | -79.8% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $100.00M | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $0 | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $100.00M | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $494.54M | – |
See a number that looks wrong?